Pentobarbital features inside the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This action potentiates GABA effects, resulting in CNS melancholy and inhibiting glutamate, even more bringing about an additive impact on CNS depression. Although the lack of an antidote has resulted in lessened very first-line usage on the drug